KYTHERA BIOPHARMACEUTICALS I - COM (KYTH)

CUSIP: 501570105

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
19,132,818
Share change
-433,159
Total reported value
$663,446,455
Put/Call ratio
1234%
Price per share
$34.68
Number of holders
104
Value change
-$13,402,758
Number of buys
44
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 501570105?
CUSIP 501570105 identifies KYTH - KYTHERA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) as of Q4 2014

As of 31 Dec 2014, KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,132,818 shares. The largest 10 holders included FMR LLC, JENNISON ASSOCIATES LLC, Palo Alto Investors, LLC, Partner Fund Management, L.P., BlackRock Fund Advisors, State Street Corp, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP LLC, Capital World Investors, and KORNITZER CAPITAL MANAGEMENT INC /KS. This page lists 104 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.